Candidate Molecular Biomarkers of Traumatic Brain Injury: A Systematic Review
- PMID: 39456216
- PMCID: PMC11506336
- DOI: 10.3390/biom14101283
Candidate Molecular Biomarkers of Traumatic Brain Injury: A Systematic Review
Abstract
Traumatic brain injury (TBI) is one of the leading causes of mortality and disability among young and middle-aged individuals. Adequate and timely diagnosis of primary brain injuries, as well as the prompt prevention and treatment of secondary injury mechanisms, significantly determine the potential for reducing mortality and severe disabling consequences. Therefore, it is crucial to have objective markers that indicate the severity of the injury. A number of molecular factors-proteins and metabolites-detected in the blood immediately after trauma and associated with the development and severity of TBI can serve in this role. TBI is a heterogeneous condition with respect to its etiology, clinical form, and genesis, being accompanied by brain cell damage and disruption of blood-brain barrier permeability. Two oppositely directed flows of substances and signals are observed: one is the flow of metabolites, proteins, and nucleic acids from damaged brain cells into the bloodstream through the damaged blood-brain barrier; the other is the infiltration of immune cells (neutrophils and macrophages) and serological proteins. Both flows aggravate brain tissue damage after TBI. Therefore, it is extremely important to study the key signaling events that regulate these flows and repair the damaged tissues, as well as to enhance the effectiveness of treatments for patients after TBI.
Keywords: biomarkers; brain injury; metabolites; plasma; proteins; serum.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.Cochrane Database Syst Rev. 2016 Jul 1;7(7):CD011020. doi: 10.1002/14651858.CD011020.pub2. Cochrane Database Syst Rev. 2016. PMID: 27364851 Free PMC article.
-
Elevation of the head during intensive care management in people with severe traumatic brain injury.Cochrane Database Syst Rev. 2017 Dec 28;12(12):CD009986. doi: 10.1002/14651858.CD009986.pub2. Cochrane Database Syst Rev. 2017. PMID: 29283434 Free PMC article.
-
Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD009221. doi: 10.1002/14651858.CD009221.pub2. Cochrane Database Syst Rev. 2015. PMID: 26624881 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Progesterone for acute traumatic brain injury.Cochrane Database Syst Rev. 2016 Dec 22;12(12):CD008409. doi: 10.1002/14651858.CD008409.pub4. Cochrane Database Syst Rev. 2016. PMID: 28005271 Free PMC article.
Cited by
-
Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury.Signal Transduct Target Ther. 2025 Jun 23;10(1):195. doi: 10.1038/s41392-025-02286-9. Signal Transduct Target Ther. 2025. PMID: 40545497 Free PMC article.
-
L-Carnitine and Mildronate Demonstrate Divergent Protective Effects on Mitochondrial DNA Quality Control and Inflammation Following Traumatic Brain Injury.Int J Mol Sci. 2025 Mar 22;26(7):2902. doi: 10.3390/ijms26072902. Int J Mol Sci. 2025. PMID: 40243464 Free PMC article.
-
Detection of NLRP3, ASC, and Caspase-1 in serum and cerebrospinal fluid of traumatic brain injury patients: implications for short-term prognosis.Acta Neurol Belg. 2025 Jun;125(3):745-755. doi: 10.1007/s13760-025-02761-8. Epub 2025 Mar 11. Acta Neurol Belg. 2025. PMID: 40067654 Free PMC article.
References
-
- CDC Let’s Prevent Traumatic Brain Injury. [(accessed on 13 May 2024)]. Available online: https://www.cpha.info/news/671673/CDC-Lets-Prevent-Traumatic-Brain-Injur....
-
- Yang L.-Y., Greig N.H., Tweedie D., Jung Y.J., Chiang Y.-H., Hoffer B.J., Miller J.P., Chang K.-H., Wang J.-Y. The P53 Inactivators Pifithrin-μ and Pifithrin-α Mitigate TBI-Induced Neuronal Damage through Regulation of Oxidative Stress, Neuroinflammation, Autophagy and Mitophagy. Exp. Neurol. 2020;324:113135. doi: 10.1016/j.expneurol.2019.113135. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical